Skip to main content
OpenTrials
Completed

NCT Number: NCT03068702

New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA)

Sickle cell maculopathy was sparingly mentioned in the literature before despite the fact that sickle cell disease or sickle cell trait is common in people of many areas of the world. This study shows that OCTA is a very valuable, non invasive, office procedure that may well be used in diagnosing this disease.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

About this study

this is a clinical study of two African Canadian patients that were diagnosed with sickle cell trait. I used OCTA to show macular vascular occlusions that usually happen with this disease.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

people with sickle cell trait or sickle cell disease -

Exclusion criteria

-

Treatment and study plan

Optical coherence tomography angiography

Device

Primary outcomes

  1. vascular changes seen in the macular vasculature of people with sickle cell disease/ trait as compared to macular vasculature of normal macula.

    Time frame: through study completion, an average of one year

    in this angiography the delicate vasculature of the macula can be clearly visualized and documented.

Sponsors and collaborators

Lead sponsor

Dr. S.S. Michel Clinic

Other

Registry information

Official study title

New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA): Sickle Cell Maculopathy

Acronym: OCTA

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Mar 3, 2017
Registry last updated
Mar 3, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.